Noninvasive Molecular Subtyping of Pediatric Low-Grade Glioma with Self-Supervised Transfer Learning.
IF 8.1
Q1 COMPUTER SCIENCE, ARTIFICIAL INTELLIGENCE
Divyanshu Tak, Zezhong Ye, Anna Zapaischykova, Yining Zha, Aidan Boyd, Sridhar Vajapeyam, Rishi Chopra, Hasaan Hayat, Sanjay P Prabhu, Kevin X Liu, Hesham Elhalawani, Ali Nabavizadeh, Ariana Familiar, Adam C Resnick, Sabine Mueller, Hugo J W L Aerts, Pratiti Bandopadhayay, Keith L Ligon, Daphne A Haas-Kogan, Tina Y Poussaint, Benjamin H Kann
下载PDF
{"title":"Noninvasive Molecular Subtyping of Pediatric Low-Grade Glioma with Self-Supervised Transfer Learning.","authors":"Divyanshu Tak, Zezhong Ye, Anna Zapaischykova, Yining Zha, Aidan Boyd, Sridhar Vajapeyam, Rishi Chopra, Hasaan Hayat, Sanjay P Prabhu, Kevin X Liu, Hesham Elhalawani, Ali Nabavizadeh, Ariana Familiar, Adam C Resnick, Sabine Mueller, Hugo J W L Aerts, Pratiti Bandopadhayay, Keith L Ligon, Daphne A Haas-Kogan, Tina Y Poussaint, Benjamin H Kann","doi":"10.1148/ryai.230333","DOIUrl":null,"url":null,"abstract":"<p><p>Purpose To develop and externally test a scan-to-prediction deep learning pipeline for noninvasive, MRI-based <i>BRAF</i> mutational status classification for pediatric low-grade glioma. Materials and Methods This retrospective study included two pediatric low-grade glioma datasets with linked genomic and diagnostic T2-weighted MRI data of patients: Dana-Farber/Boston Children's Hospital (development dataset, <i>n</i> = 214 [113 (52.8%) male; 104 (48.6%) <i>BRAF</i> wild type, 60 (28.0%) <i>BRAF</i> fusion, and 50 (23.4%) <i>BRAF</i> V600E]) and the Children's Brain Tumor Network (external testing, <i>n</i> = 112 [55 (49.1%) male; 35 (31.2%) <i>BRAF</i> wild type, 60 (53.6%) <i>BRAF</i> fusion, and 17 (15.2%) <i>BRAF</i> V600E]). A deep learning pipeline was developed to classify <i>BRAF</i> mutational status (<i>BRAF</i> wild type vs <i>BRAF</i> fusion vs <i>BRAF</i> V600E) via a two-stage process: <i>(a)</i> three-dimensional tumor segmentation and extraction of axial tumor images and <i>(b)</i> section-wise, deep learning-based classification of mutational status. Knowledge-transfer and self-supervised approaches were investigated to prevent model overfitting, with a primary end point of the area under the receiver operating characteristic curve (AUC). To enhance model interpretability, a novel metric, center of mass distance, was developed to quantify the model attention around the tumor. Results A combination of transfer learning from a pretrained medical imaging-specific network and self-supervised label cross-training (TransferX) coupled with consensus logic yielded the highest classification performance with an AUC of 0.82 (95% CI: 0.72, 0.91), 0.87 (95% CI: 0.61, 0.97), and 0.85 (95% CI: 0.66, 0.95) for <i>BRAF</i> wild type, <i>BRAF</i> fusion, and <i>BRAF</i> V600E, respectively, on internal testing. On external testing, the pipeline yielded an AUC of 0.72 (95% CI: 0.64, 0.86), 0.78 (95% CI: 0.61, 0.89), and 0.72 (95% CI: 0.64, 0.88) for <i>BRAF</i> wild type, <i>BRAF</i> fusion, and <i>BRAF</i> V600E, respectively. Conclusion Transfer learning and self-supervised cross-training improved classification performance and generalizability for noninvasive pediatric low-grade glioma mutational status prediction in a limited data scenario. <b>Keywords:</b> Pediatrics, MRI, CNS, Brain/Brain Stem, Oncology, Feature Detection, Diagnosis, Supervised Learning, Transfer Learning, Convolutional Neural Network (CNN) <i>Supplemental material is available for this article.</i> © RSNA, 2024.</p>","PeriodicalId":29787,"journal":{"name":"Radiology-Artificial Intelligence","volume":null,"pages":null},"PeriodicalIF":8.1000,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11140508/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Radiology-Artificial Intelligence","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1148/ryai.230333","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"COMPUTER SCIENCE, ARTIFICIAL INTELLIGENCE","Score":null,"Total":0}
引用次数: 0
引用
批量引用
Abstract
Purpose To develop and externally test a scan-to-prediction deep learning pipeline for noninvasive, MRI-based BRAF mutational status classification for pediatric low-grade glioma. Materials and Methods This retrospective study included two pediatric low-grade glioma datasets with linked genomic and diagnostic T2-weighted MRI data of patients: Dana-Farber/Boston Children's Hospital (development dataset, n = 214 [113 (52.8%) male; 104 (48.6%) BRAF wild type, 60 (28.0%) BRAF fusion, and 50 (23.4%) BRAF V600E]) and the Children's Brain Tumor Network (external testing, n = 112 [55 (49.1%) male; 35 (31.2%) BRAF wild type, 60 (53.6%) BRAF fusion, and 17 (15.2%) BRAF V600E]). A deep learning pipeline was developed to classify BRAF mutational status (BRAF wild type vs BRAF fusion vs BRAF V600E) via a two-stage process: (a) three-dimensional tumor segmentation and extraction of axial tumor images and (b) section-wise, deep learning-based classification of mutational status. Knowledge-transfer and self-supervised approaches were investigated to prevent model overfitting, with a primary end point of the area under the receiver operating characteristic curve (AUC). To enhance model interpretability, a novel metric, center of mass distance, was developed to quantify the model attention around the tumor. Results A combination of transfer learning from a pretrained medical imaging-specific network and self-supervised label cross-training (TransferX) coupled with consensus logic yielded the highest classification performance with an AUC of 0.82 (95% CI: 0.72, 0.91), 0.87 (95% CI: 0.61, 0.97), and 0.85 (95% CI: 0.66, 0.95) for BRAF wild type, BRAF fusion, and BRAF V600E, respectively, on internal testing. On external testing, the pipeline yielded an AUC of 0.72 (95% CI: 0.64, 0.86), 0.78 (95% CI: 0.61, 0.89), and 0.72 (95% CI: 0.64, 0.88) for BRAF wild type, BRAF fusion, and BRAF V600E, respectively. Conclusion Transfer learning and self-supervised cross-training improved classification performance and generalizability for noninvasive pediatric low-grade glioma mutational status prediction in a limited data scenario. Keywords: Pediatrics, MRI, CNS, Brain/Brain Stem, Oncology, Feature Detection, Diagnosis, Supervised Learning, Transfer Learning, Convolutional Neural Network (CNN) Supplemental material is available for this article. © RSNA, 2024.
利用自我监督转移学习对小儿低级别胶质瘤进行无创分子亚型分析
"刚刚接受 "的论文经过同行评审,已被接受在《放射学》上发表:人工智能》上发表。这篇文章在以最终版本发表之前,还将经过校对、排版和校对审核。请注意,在制作最终校对稿的过程中,可能会发现影响内容的错误。目的 为基于 MRI 的小儿低级别胶质瘤(pLGG)无创 BRAF 突变状态分类开发一种扫描到预测的深度学习管道,并对其进行外部测试。材料与方法 这项回顾性研究包括两个 pLGG 数据集,其中包含患者的基因组和诊断 T2 加权 MRI 数据:BCH(开发数据集,n = 214 [60 (28%) BRAF-Fusion, 50 (23%) BRAF V600E, 104 (49%) 野生型])和儿童脑肿瘤网络(外部测试,n = 112 [60 (53%) BRAF-Fusion, 17 (15%) BRAF-V600E, 35 (32%) 野生型])。我们开发了一个深度学习管道,通过两个阶段对 BRAF 突变状态(V600E 与融合型与野生型)进行分类:1)轴向肿瘤图像的三维肿瘤分割和提取;2)基于深度学习的突变状态切片分类。我们研究了知识转移和自我监督方法,以防止模型过拟合,主要终点是接收者操作特征曲线下面积(AUC)。为了提高模型的可解释性,我们开发了一种新的指标--COMDist(质量中心距离),用于量化肿瘤周围的模型关注度。结果 在内部测试中,来自预训练医学影像特定网络的迁移学习和自监督标签交叉训练(TransferX)与共识逻辑相结合产生了最高的分类性能,对于野生型、BRAF-融合型和BRAF-V600E的AUC分别为0.82[95% CI:0.72-0.91]、0.87[95% CI:0.61-0.97]和0.85[95% CI:0.66-0.95]。在外部测试中,野生型、BRAF-融合型和 BRAF-V600E 类别的 AUC 分别为 0.72 [95% CI: 0.64-0.86]、0.78 [95% CI: 0.61-0.89] 和 0.72 [95% CI: 0.64-0.88]。结论 在数据有限的情况下,迁移学习和自我监督交叉训练提高了无创 pLGG 突变状态预测的分类性能和普适性。©RSNA, 2024.
本文章由计算机程序翻译,如有差异,请以英文原文为准。